FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118079648> ?p ?o ?g. }

• W3118079648 abstract "ABSTRACT Background Glioblastoma multiforme (GBM) is a type of high-grade brain tumor known for its proliferative, invasive property, and low survival rate. Recently, with the advancement in therapeutics for tumors such as targeted therapy, individual cancer-specific biomarkers could be recognized as targets for curative purposes. This study identified six differentially expressed genes that have shown significant implications in clinical field, including FPR2, VEGFA, SERPINA1, SOX2, PBK, and ITGB3. FPR2 was of the same protein family with FPR1, and the latter has been repeatedly reported to promote motility and invasiveness of multiple tumor forms. Methods The gene expression profiling of 40 GBM samples and five normal samples from the TCGA database were comprehensively analyzed. The differentially expressed genes (DEGs) were identified using R package and screened by enrichment analysis and examination of protein–protein interaction networks, in order to further explore the functions of DEGs with the highest association with clinical traits and to find hub genes. A qRT-PCR and Western blots were conducted to verify the results of this study. Results Our investigation showed that FPR2, VEGFA, SERPINA1, SOX2, PBK, and ITGB3 were significantly up-regulated in GBM primary tumor compared to the control group. Functional enrichment analysis of the DEGs demonstrated that biological functions related to immune systems, cell division and cell cycle were significantly increased, which were closely related to tumor progression and development. Downstream construction of PPI network analysis indicated that FPR2 was a hub gene involved in high level of interaction with CR3 and VEGFA, which played a key role in inflammatory pathways and cellular dysfunction. Conclusion FPR2, VEGFA, SERPINA1, SOX2, PBK, and ITGB3 were significantly over-expressed in primary tumor samples of GBM patients and were involved in cellular functions and pathways contributing to tumor progression. Out of these six pivotal genes, we intensively focused on FPR2, and our analysis and experimental data both suggested its efficacy as a potential biomarker, serving as an alternative immunotherapeutic target for glioblastoma multiforme." @default.
• W3118079648 created "2021-01-05" @default.
• W3118079648 creator A5010491862 @default.
• W3118079648 creator A5028977817 @default.
• W3118079648 creator A5030741127 @default.
• W3118079648 creator A5032293416 @default.
• W3118079648 creator A5064372450 @default.
• W3118079648 creator A5067232234 @default.
• W3118079648 creator A5076781720 @default.
• W3118079648 creator A5087217720 @default.
• W3118079648 creator A5089112710 @default.
• W3118079648 date "2020-12-27" @default.
• W3118079648 modified "2023-09-26" @default.
• W3118079648 title "Genomic profiling of cancerous patients identifies FPR2 as an alternative immunotherapeutic target in glioblastoma multiforme" @default.
• W3118079648 cites W1974713792 @default.
• W3118079648 cites W1990956893 @default.
• W3118079648 cites W1996851911 @default.
• W3118079648 cites W2008318585 @default.
• W3118079648 cites W2011799827 @default.
• W3118079648 cites W2023885856 @default.
• W3118079648 cites W2024059336 @default.
• W3118079648 cites W2027618012 @default.
• W3118079648 cites W2072291517 @default.
• W3118079648 cites W2073406358 @default.
• W3118079648 cites W2096287682 @default.
• W3118079648 cites W2100239923 @default.
• W3118079648 cites W2107281275 @default.
• W3118079648 cites W2109518572 @default.
• W3118079648 cites W2122683221 @default.
• W3118079648 cites W2154621334 @default.
• W3118079648 cites W2158485828 @default.
• W3118079648 cites W2167560492 @default.
• W3118079648 cites W2171815113 @default.
• W3118079648 cites W2240292514 @default.
• W3118079648 cites W2270107170 @default.
• W3118079648 cites W2386040222 @default.
• W3118079648 cites W2436534309 @default.
• W3118079648 cites W2579217144 @default.
• W3118079648 cites W2614794838 @default.
• W3118079648 cites W2753385986 @default.
• W3118079648 cites W2763960534 @default.
• W3118079648 cites W2781707679 @default.
• W3118079648 cites W2796153225 @default.
• W3118079648 cites W2810058421 @default.
• W3118079648 cites W2886558503 @default.
• W3118079648 cites W2892352888 @default.
• W3118079648 cites W2921939018 @default.
• W3118079648 cites W2953251387 @default.
• W3118079648 cites W2955230524 @default.
• W3118079648 cites W2968100692 @default.
• W3118079648 cites W2979624544 @default.
• W3118079648 cites W3001143457 @default.
• W3118079648 cites W3029096262 @default.
• W3118079648 cites W3043754520 @default.
• W3118079648 cites W3053264094 @default.
• W3118079648 cites W4231824804 @default.
• W3118079648 doi "https://doi.org/10.1101/2020.12.26.424414" @default.
• W3118079648 hasPublicationYear "2020" @default.
• W3118079648 type Work @default.
• W3118079648 sameAs 3118079648 @default.
• W3118079648 citedByCount "1" @default.
• W3118079648 countsByYear W31180796482022 @default.
• W3118079648 crossrefType "posted-content" @default.
• W3118079648 hasAuthorship W3118079648A5010491862 @default.
• W3118079648 hasAuthorship W3118079648A5028977817 @default.
• W3118079648 hasAuthorship W3118079648A5030741127 @default.
• W3118079648 hasAuthorship W3118079648A5032293416 @default.
• W3118079648 hasAuthorship W3118079648A5064372450 @default.
• W3118079648 hasAuthorship W3118079648A5067232234 @default.
• W3118079648 hasAuthorship W3118079648A5076781720 @default.
• W3118079648 hasAuthorship W3118079648A5087217720 @default.
• W3118079648 hasAuthorship W3118079648A5089112710 @default.
• W3118079648 hasBestOaLocation W31180796481 @default.
• W3118079648 hasConcept C104317684 @default.
• W3118079648 hasConcept C150194340 @default.
• W3118079648 hasConcept C18431079 @default.
• W3118079648 hasConcept C2776194525 @default.
• W3118079648 hasConcept C2777933648 @default.
• W3118079648 hasConcept C502942594 @default.
• W3118079648 hasConcept C54355233 @default.
• W3118079648 hasConcept C70721500 @default.
• W3118079648 hasConcept C86339819 @default.
• W3118079648 hasConcept C86803240 @default.
• W3118079648 hasConceptScore W3118079648C104317684 @default.
• W3118079648 hasConceptScore W3118079648C150194340 @default.
• W3118079648 hasConceptScore W3118079648C18431079 @default.
• W3118079648 hasConceptScore W3118079648C2776194525 @default.
• W3118079648 hasConceptScore W3118079648C2777933648 @default.
• W3118079648 hasConceptScore W3118079648C502942594 @default.
• W3118079648 hasConceptScore W3118079648C54355233 @default.
• W3118079648 hasConceptScore W3118079648C70721500 @default.
• W3118079648 hasConceptScore W3118079648C86339819 @default.
• W3118079648 hasConceptScore W3118079648C86803240 @default.
• W3118079648 hasLocation W31180796481 @default.
• W3118079648 hasOpenAccess W3118079648 @default.
• W3118079648 hasPrimaryLocation W31180796481 @default.
• W3118079648 hasRelatedWork W23940660 @default.
• W3118079648 hasRelatedWork W27958817 @default.
• W3118079648 hasRelatedWork W31615066 @default.
• W3118079648 hasRelatedWork W35996398 @default.

• next